Conference Day Two

Download your copy of the full event guide for a comprehensive view of all 3 conference days.

7:45 am
Morning Networking Coffee

8:15 am Chair’s Opening Remarks

Understanding the Regulatory Path for Established & Emerging mRNA Technologies

8:30 am An Exclusive Overview of the Regulatory Environment & Regulatory Strategy for mRNA Vaccines

Synopsis

For more information on this session, please download the full event guide.

9:00 am Reserved for ThermoFisher

9:30 am Utilising mRNA Gene Editing Techniques to Engineer Novel NK Cells & Overcome Regulatory Hurdles

  • Aviad Pato Head of Research & Natural Killer Cells, Gamida Cell

Synopsis

For more information on this session, please download the full event guide.

10:00 am Navigating the Challenges & Opportunities in mRNA Drug Product Manufacturing

  • May Guo Vice President, Nucleic Acids, Arranta Bio

Synopsis

For more information on this session, please download the full event guide.

10:30 am
Morning Refreshment Break & Poster Session

12:30 pm Reserved for eTheRNA Immunotherapies

12:40 pm
Networking Lunch Break

From Discovery to Clinical Development: Paving the Path Forward for Better Clinical Translation

2:00 pm Panel Discussion: How to Streamline Practices for mRNA- Based Therapeutics Across the Development Value Chain & Overcome Key Bottlenecks for Better Clinical Translation

  • Andreas Kuhn Senior Vice President RNA Biochemistry & Manufacturing, RNA Biochemistry & Manufacturing, BioNTech
  • Danilo Casimiro Chief Science Officer & Global Head, External Scientific Affairs, Vaccines R&D, Sanofi
  • Gregory Fiore Co-Founder & Chief Executive Officer, Exacis Biotherapeutics

Synopsis

For more information on this session, please download the full event guide.

2:30 pm
Afternoon Networking Break

Developing Tomorrow’s mRNA-Based Therapies

3:00 pm Session Reserved for Sartorius

3:30 pm Assessing Synthetic Circular RNA (oRNATM) as a New Therapeutic Modality

  • Nelson Chau Senior Vice President - Platform, Orna Therapeutics

Synopsis

For more information on this session, please download the full event guide.

4:00 pm Accelerating the Development of mRNA-Based Therapeutics

  • Ioana Panait Lead Research Analyst, Beacon Targeted Therapies

Synopsis

For more information on this session, please download the full event guide.

4:30 pm
Chair’s Closing Remarks & End of 2nd Annual mRNA-Based Therapeutics Summit Europe 2023